NASDAQ:OFIX - Orthofix Medical Stock Price, Forecast & News

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Orthofix Medical Inc (NASDAQ:OFIX) issued its earnings results on Monday, February, 24th. The medical device company reported $0.51 EPS for the quarter, hitting analysts' consensus estimates of $0.51. The medical device company earned $121.49 million during the quarter, compared to the consensus estimate of $122.90 million. Orthofix Medical had a negative net margin of 6.19% and a positive return on equity of 8.55%. View Orthofix Medical's Earnings History.

Orthofix Medical is scheduled to release their next quarterly earnings announcement on Monday, May 4th 2020. View Earnings Estimates for Orthofix Medical.

Orthofix Medical issued an update on its first quarter 2020 After-Hours earnings guidance on Monday, February, 24th. The company provided earnings per share guidance of 0.09-0.12 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.32. The company issued revenue guidance of $106-109 million, compared to the consensus revenue estimate of $113.27 million.

3 brokers have issued 12 month price objectives for Orthofix Medical's stock. Their forecasts range from $42.00 to $56.00. On average, they anticipate Orthofix Medical's share price to reach $49.00 in the next year. This suggests a possible upside of 33.5% from the stock's current price. View Analyst Price Targets for Orthofix Medical.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Orthofix Medical.

Headlines about OFIX stock have been trending somewhat positive this week, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Orthofix Medical earned a news impact score of 1.8 on InfoTrie's scale. They also gave news articles about the medical device company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Orthofix Medical.

Orthofix Medical saw a decline in short interest in the month of January. As of January 31st, there was short interest totalling 316,400 shares, a decline of 14.9% from the January 15th total of 371,800 shares. Based on an average daily trading volume, of 146,900 shares, the days-to-cover ratio is presently 2.2 days. Currently, 1.7% of the company's shares are sold short. View Orthofix Medical's Current Options Chain.

Some companies that are related to Orthofix Medical include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), IDEXX Laboratories (IDXX), Teleflex (TFX), Steris (STE), Hologic (HOLX) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Exxon Mobil (XOM), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Gilead Sciences (GILD), iCAD (ICAD), Intercept Pharmaceuticals (ICPT), Madrigal Pharmaceuticals (MDGL) and Zogenix (ZGNX).

Orthofix Medical's stock is owned by a number of of institutional and retail investors. Top institutional investors include Paradice Investment Management LLC (4.36%), State Street Corp (3.59%), Goldman Sachs Group Inc. (2.64%), Dalton Greiner Hartman Maher & Co. (2.23%), Renaissance Technologies LLC (1.94%) and Geode Capital Management LLC (1.65%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix Medical.

OFIX stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., Marshall Wace LLP, Mackay Shields LLC, AJO LP, Renaissance Technologies LLC, SG Americas Securities LLC and Geode Capital Management LLC. View Insider Buying and Selling for Orthofix Medical.

OFIX stock was bought by a variety of institutional investors in the last quarter, including Royce & Associates LP, Dalton Greiner Hartman Maher & Co., Bank of Montreal Can, Jacobs Levy Equity Management Inc., Great West Life Assurance Co. Can, Thrivent Financial for Lutherans, Paradice Investment Management LLC and Charles Schwab Investment Management Inc.. View Insider Buying and Selling for Orthofix Medical.

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OFIX stock can currently be purchased for approximately $36.70.

Orthofix Medical has a market capitalization of $699.50 million and generates $459.95 million in revenue each year. The medical device company earns $13.81 million in net income (profit) each year or $1.47 on an earnings per share basis. Orthofix Medical employs 954 workers across the globe.View Additional Information About Orthofix Medical.

The official website for Orthofix Medical is http://www.orthofix.com/.

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]